Literature DB >> 19004564

A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome.

Christopher Exley1, Louise Swarbrick, Rhomain K Gherardi, Francois-Jérôme Authier.   

Abstract

Macrophagic myofasciitis and chronic fatigue syndrome are severely disabling conditions which may be caused by adverse reactions to aluminium-containing adjuvants in vaccines. While a little is known of disease aetiology both conditions are characterised by an aberrant immune response, have a number of prominent symptoms in common and are coincident in many individuals. Herein, we have described a case of vaccine-associated chronic fatigue syndrome and macrophagic myofasciitis in an individual demonstrating aluminium overload. This is the first report linking the latter with either of these two conditions and the possibility is considered that the coincident aluminium overload contributed significantly to the severity of these conditions in this individual. This case has highlighted potential dangers associated with aluminium-containing adjuvants and we have elucidated a possible mechanism whereby vaccination involving aluminium-containing adjuvants could trigger the cascade of immunological events which are associated with autoimmune conditions including chronic fatigue syndrome and macrophagic myofasciitis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19004564     DOI: 10.1016/j.mehy.2008.09.040

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  22 in total

1.  A young man with persistent myalgia and fatigue: an off-label therapeutic approach.

Authors:  Gaspare Elios Russo; Virgilio De Bono; Dmytro Grynyshyn; Tania Gnerre Musto; Massimo Testorio; Cristina Crespini; Andrea Martinez; Alessio Molfino; Silvia Lai
Journal:  Intern Emerg Med       Date:  2014-10-17       Impact factor: 3.397

Review 2.  Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts.

Authors:  Calvin C Willhite; Nataliya A Karyakina; Robert A Yokel; Nagarajkumar Yenugadhati; Thomas M Wisniewski; Ian M F Arnold; Franco Momoli; Daniel Krewski
Journal:  Crit Rev Toxicol       Date:  2014-10       Impact factor: 5.635

3.  Macrophagic myofasciitis and vaccination: consequence or coincidence?

Authors:  Tânia Santiago; Olinda Rebelo; Luís Negrão; Anabela Matos
Journal:  Rheumatol Int       Date:  2014-06-13       Impact factor: 2.631

Review 4.  Macrophagic myofaciitis a vaccine (alum) autoimmune-related disease.

Authors:  Eitan Israeli; Nancy Agmon-Levin; Miri Blank; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

5.  Macrophagic myofasciitis: characterization and pathophysiology.

Authors:  R K Gherardi; F J Authier
Journal:  Lupus       Date:  2012-02       Impact factor: 2.911

Review 6.  Advances in aluminum hydroxide-based adjuvant research and its mechanism.

Authors:  Peng He; Yening Zou; Zhongyu Hu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 7.  Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity.

Authors:  C A Shaw; L Tomljenovic
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

8.  Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration.

Authors:  Christopher A Shaw; Michael S Petrik
Journal:  J Inorg Biochem       Date:  2009-08-20       Impact factor: 4.155

9.  Autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA syndrome) in commercial sheep.

Authors:  Lluís Luján; Marta Pérez; Eider Salazar; Neila Álvarez; Marina Gimeno; Pedro Pinczowski; Silvia Irusta; Jesús Santamaría; Nerea Insausti; Yerzol Cortés; Luis Figueras; Isabel Cuartielles; Miguel Vila; Enrique Fantova; José Luis Gracia Chapullé
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

10.  Revisiting the Sham: Is It all Smoke and Mirrors?

Authors:  Brandon Horn; Judith Balk; Jeffrey I Gold
Journal:  Evid Based Complement Alternat Med       Date:  2011-04-14       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.